Intuitive Surgical's stock drops as revenue misses Street view
Intuitive Surgical Inc. (ISRG) shares fell in the extended session Thursday after the surgical robotics company's quarterly revenue missed Wall Street estimates. Intuitive Surgical shares fell as much as 8% after hours, following a 0.8% rise to close the regular session at $273.45. The company reported third-quarter net income of $415.7 million, or $1.16 a share, compared with $324.7 million, or 90 cents a share, in the year-ago period. Adjusted earnings, which exclude stock-based compensation expenses and other items, were $1.46 a share, compared with $1.19 a share in the year-go period. Revenue rose to $1.74 billion from $1.56 billion in the year-ago quarter. Analysts surveyed by FactSet had forecast $1.42 a share on revenue of $1.77 billion.
-Wallace Witkowski
This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.
(END) Dow Jones Newswires
10-19-23 1626ET
Copyright (c) 2023 Dow Jones & Company, Inc.-
Should Emerging-Markets Stocks Stand Alone in Your Portfolio?
-
What’s Happening in the Markets This Week
-
Worst-Performing Stock ETFs of the Quarter
-
Q3 in Review and Q4 2024 Market Outlook
-
Top-Performing Stock ETFs of the Quarter
-
September Jobs Report Forecasts Show Moderate Hiring Gains
-
Port Strike a Headache for Shippers but a Potential Tailwind for Certain US Transport Stocks
-
13 Charts on Q3′s Roller-Coaster Rally for Stocks and Bonds
-
3 Dividend Stocks for October 2024
-
Consumer Defensives: Despite Angst, Thirsty Investors Have Names to Pursue
-
Industrials: Many Stocks Overvalued After Q3 Outperformance
-
Basic Materials: Despite Index Rise, We See Multiple Long-Term Opportunities
-
What the Election Could Mean for Big Tech Stocks
-
3 Lessons From Recent Stock Market Drama
-
Consumer Cyclicals: Even Amid Moderating Consumer Spending, We See Discounts
-
Healthcare: Valuations Look Fair Overall, With Select Industries Still Undervalued